Catena Biosciences

2630 Bancroft Way


Developer of an advanced protein coupling technology intended to cure autoimmune disorders. The company’s platform enables the joining of any two soluble proteins together with minimal engineering and without restrictions due to protein size or complexity and uses naturally occurring amino acids, which is more widely applicable and can be used to create complicated constructs, helping clients in the creation of novel therapeutics in autoimmune disorders, oncology, and vaccine development.